LBCA Scientific Blog: Rita Mukhtar, MD
LBCA Scientific Advisory Board Member Discusses Ongoing Clinical Research in ILC Breast cancer surgeons are often the first physicians to meet with patients after a
LBCA Scientific Advisory Board Member Discusses Ongoing Clinical Research in ILC Breast cancer surgeons are often the first physicians to meet with patients after a
Invasive lobular carcinoma (ILC) research and the Lobular Breast Cancer Alliance (LBCA) will both have a presence at this year’s San Antonio Breast Cancer Symposium
Many women diagnosed with lobular breast cancer have found their way to the Lobular Breast Cancer Alliance (LBCA). So have many of their friends and
The 2020 San Antonio Breast Cancer Symposium (SABCS) saw more posters than ever focused on lobular breast cancer. One goal of the Lobular Breast Cancer
Frequently Asked Questions About ILC These Frequently Asked Questions (FAQs) and their answers about invasive lobular carcinoma (ILC), also known as lobular breast cancer, are
The Lobular Breast Cancer Alliance keeps its invasive lobular carcinoma (ILC) information and research cutting edge with the guidance of a Scientific Advisory Board (SAB)
by LBCA Steering Committee member Diane Mapes (aka @double_whammied) Report from ASCO 2019:Â Q & A with Dr. Otto Metzger The 2019 annual meeting of the
The Lobular Breast Cancer Alliance (LBCA) has compiled a reference list of research publications related to lobular breast cancer, also known as invasive lobular carcinoma
Physicians and researchers answer patient questions about ILC
Lobular Breast Cancer Alliance Inc. (LBCA) is a Delaware nonprofit corporation that is registered as a 501(c)(3) public charity. Tax ID Number: 86-2260246. Donations to LBCA are tax-deductible. to the fullest extent allowed by applicable law.
© 2024 The Lobular Breast Cancer Alliance Inc. | Privacy Policy | Terms of Use | State Fundraising Notices
Site by SuzanneHarrisonWeb.com